Predictive power of GHGE and CED on nutritional and anthropometric parameters were presented in Figs
doi: 10.1146/annurev-pharmtox-011112-140320, 151
Where the Science Is Headed Now The next phase of the GLP-1 story is less about format and more about stability in the body over time, a shift that became tangible in December 2025 when the FDA approved Novo Nordisks oral semaglutide (Wegovy), the first daily GLP-1 pill cleared for obesity treatment
However, the concepts of fragility and anti-fragility, recently put forward by Taleb (2012) and Aven (2015), aim not only to provide resilience against these shocks, but also to strengthen them by feeding on uncertainties and complexities
Ingredients: L-Arginine 1500 mg, L-Carnitine 500 mg, Acetyl-L-Carnitine 250 mg, Myo-Inositol 650 mg, Coenzyme Q10 30 mg, Magnesium 60 mg , Zinc 15 mg , Selenium 55 g , Copper 1 mg , Vitamin E 18 mg , Vitamin D 10 g , Vitamin C 60 mg , Vitamin B1 1,1 mg , Vitamin B2 1,4 mg , Vitamin B3 16 mg , Vitamin B6 2,1 mg , Vitamin B12 2,5 g , Folic acid 400 g , Biotin 50 g , Pantothenic acid 6 mg